Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetic Nephropathies | 25 | 2024 | 973 | 4.400 |
Why?
|
Glucosephosphate Dehydrogenase | 21 | 2024 | 210 | 4.190 |
Why?
|
Endocrinology | 19 | 2023 | 442 | 2.590 |
Why?
|
Diabetes Mellitus | 24 | 2023 | 5841 | 1.600 |
Why?
|
NADP | 8 | 2017 | 227 | 1.270 |
Why?
|
Albuminuria | 7 | 2018 | 657 | 1.040 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2023 | 2243 | 1.010 |
Why?
|
Acidosis, Lactic | 2 | 2015 | 146 | 0.900 |
Why?
|
Oxidative Stress | 10 | 2018 | 3113 | 0.850 |
Why?
|
Hyperglycemia | 6 | 2021 | 1376 | 0.810 |
Why?
|
Standard of Care | 20 | 2023 | 551 | 0.780 |
Why?
|
Kidney | 15 | 2021 | 7047 | 0.780 |
Why?
|
Reference Standards | 19 | 2023 | 1003 | 0.770 |
Why?
|
Isoproterenol | 1 | 2021 | 395 | 0.750 |
Why?
|
Hypoglycemic Agents | 4 | 2018 | 3085 | 0.720 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2021 | 215 | 0.710 |
Why?
|
Athletic Performance | 2 | 2020 | 111 | 0.680 |
Why?
|
Lactates | 1 | 2019 | 405 | 0.620 |
Why?
|
Pentose Phosphate Pathway | 7 | 2018 | 126 | 0.610 |
Why?
|
Metformin | 2 | 2015 | 906 | 0.580 |
Why?
|
Glucose | 8 | 2021 | 4346 | 0.550 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 2018 | 1119 | 0.550 |
Why?
|
Thigh | 1 | 2016 | 241 | 0.490 |
Why?
|
Medical Audit | 1 | 2016 | 453 | 0.480 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2024 | 12148 | 0.480 |
Why?
|
Sodium-Glucose Transporter 2 | 2 | 2017 | 89 | 0.470 |
Why?
|
Glomerular Filtration Rate | 8 | 2017 | 2177 | 0.460 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 2 | 2017 | 94 | 0.460 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2018 | 311 | 0.450 |
Why?
|
Diabetes Mellitus, Type 1 | 8 | 2017 | 3415 | 0.450 |
Why?
|
Societies, Medical | 19 | 2023 | 3905 | 0.420 |
Why?
|
Oligonucleotides | 2 | 2012 | 582 | 0.410 |
Why?
|
Oligonucleotides, Antisense | 4 | 2012 | 461 | 0.400 |
Why?
|
Exercise Test | 2 | 2016 | 2127 | 0.390 |
Why?
|
Glycosuria, Renal | 1 | 2011 | 4 | 0.390 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 4 | 2012 | 484 | 0.360 |
Why?
|
Blood Pressure | 6 | 2018 | 8481 | 0.330 |
Why?
|
Glucosides | 1 | 2013 | 512 | 0.320 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2645 | 0.310 |
Why?
|
Kidney Diseases | 2 | 2017 | 2091 | 0.300 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1779 | 0.300 |
Why?
|
Oxygen | 1 | 2019 | 4227 | 0.290 |
Why?
|
Kidney Failure, Chronic | 6 | 2017 | 2472 | 0.290 |
Why?
|
Benzhydryl Compounds | 1 | 2013 | 916 | 0.280 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2013 | 1039 | 0.270 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 1516 | 0.270 |
Why?
|
Nitric Oxide | 6 | 2017 | 2135 | 0.270 |
Why?
|
Luminescent Proteins | 2 | 2021 | 837 | 0.260 |
Why?
|
Reactive Oxygen Species | 8 | 2019 | 2141 | 0.240 |
Why?
|
Antioxidants | 4 | 2012 | 1668 | 0.240 |
Why?
|
Cell Survival | 2 | 2012 | 5791 | 0.240 |
Why?
|
Mitochondria | 4 | 2021 | 3624 | 0.240 |
Why?
|
Mental Health Services | 1 | 2016 | 1730 | 0.230 |
Why?
|
Animals | 38 | 2024 | 168467 | 0.230 |
Why?
|
Podocytes | 2 | 2019 | 405 | 0.220 |
Why?
|
Hemodynamics | 2 | 2013 | 4160 | 0.220 |
Why?
|
Humans | 66 | 2024 | 761572 | 0.210 |
Why?
|
Renin-Angiotensin System | 2 | 2021 | 737 | 0.210 |
Why?
|
Rats | 13 | 2024 | 23741 | 0.210 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 901 | 0.200 |
Why?
|
Blood Glucose | 4 | 2018 | 6391 | 0.200 |
Why?
|
Cell Death | 3 | 2014 | 1679 | 0.200 |
Why?
|
Glycolysis | 4 | 2019 | 835 | 0.200 |
Why?
|
Losartan | 1 | 2003 | 265 | 0.200 |
Why?
|
Cyclic AMP | 3 | 2007 | 1463 | 0.190 |
Why?
|
Mentors | 1 | 2007 | 661 | 0.190 |
Why?
|
Catalase | 2 | 2018 | 218 | 0.180 |
Why?
|
Hypertension | 2 | 2015 | 8540 | 0.180 |
Why?
|
Basketball | 1 | 2020 | 46 | 0.180 |
Why?
|
Schools, Medical | 1 | 2007 | 879 | 0.180 |
Why?
|
Platelet-Derived Growth Factor | 2 | 1994 | 618 | 0.180 |
Why?
|
Proteinuria | 2 | 2014 | 607 | 0.170 |
Why?
|
Endothelial Cells | 1 | 2012 | 3548 | 0.170 |
Why?
|
Cattle | 7 | 2012 | 3849 | 0.160 |
Why?
|
Thymidine | 3 | 2012 | 299 | 0.160 |
Why?
|
Interleukin-1 | 1 | 2002 | 1248 | 0.160 |
Why?
|
Mental Disorders | 2 | 2016 | 6845 | 0.160 |
Why?
|
Tumor Cells, Cultured | 3 | 2002 | 6132 | 0.160 |
Why?
|
Endothelium, Vascular | 5 | 2007 | 4431 | 0.160 |
Why?
|
RNA, Small Interfering | 2 | 2021 | 3430 | 0.160 |
Why?
|
Program Evaluation | 1 | 2007 | 2495 | 0.160 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2021 | 1693 | 0.150 |
Why?
|
Kallikrein-Kinin System | 1 | 2017 | 9 | 0.150 |
Why?
|
Oxidation-Reduction | 5 | 2014 | 2231 | 0.150 |
Why?
|
Education, Medical, Undergraduate | 1 | 2007 | 1070 | 0.150 |
Why?
|
Kidney Cortex | 2 | 2009 | 169 | 0.150 |
Why?
|
Genes, Reporter | 1 | 2021 | 1529 | 0.140 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 496 | 0.140 |
Why?
|
Patient-Centered Care | 1 | 2007 | 1421 | 0.140 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2023 | 710 | 0.140 |
Why?
|
Epidermal Growth Factor | 2 | 1991 | 702 | 0.140 |
Why?
|
Mice | 14 | 2019 | 81533 | 0.140 |
Why?
|
Retinal Diseases | 1 | 2023 | 705 | 0.140 |
Why?
|
Coagulants | 1 | 2016 | 45 | 0.140 |
Why?
|
Creatinine | 6 | 2017 | 1899 | 0.130 |
Why?
|
NAD | 1 | 2000 | 614 | 0.130 |
Why?
|
Transfection | 5 | 2012 | 5774 | 0.130 |
Why?
|
Autophagy | 1 | 2024 | 1326 | 0.130 |
Why?
|
Cell Line | 6 | 2024 | 15601 | 0.130 |
Why?
|
Kidney Tubules, Proximal | 3 | 2024 | 383 | 0.130 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2017 | 295 | 0.130 |
Why?
|
Energy Metabolism | 2 | 2019 | 2882 | 0.130 |
Why?
|
Superoxide Dismutase | 1 | 2018 | 594 | 0.130 |
Why?
|
Pyruvate Kinase | 1 | 2017 | 189 | 0.120 |
Why?
|
Kallikreins | 1 | 2016 | 220 | 0.120 |
Why?
|
HEK293 Cells | 2 | 2021 | 4280 | 0.120 |
Why?
|
Paraquat | 1 | 2014 | 32 | 0.120 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11904 | 0.120 |
Why?
|
Enzyme Activation | 3 | 2012 | 3597 | 0.120 |
Why?
|
Endpoint Determination | 1 | 2017 | 590 | 0.110 |
Why?
|
Ubiquitination | 1 | 2019 | 1007 | 0.110 |
Why?
|
Dimerization | 1 | 2015 | 891 | 0.110 |
Why?
|
Antihypertensive Agents | 1 | 2003 | 2024 | 0.110 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 1994 | 178 | 0.110 |
Why?
|
Aorta | 2 | 2001 | 2041 | 0.110 |
Why?
|
Students, Medical | 1 | 2007 | 1936 | 0.110 |
Why?
|
Cystatin C | 2 | 2012 | 270 | 0.110 |
Why?
|
Male | 29 | 2024 | 360842 | 0.110 |
Why?
|
Cell Division | 3 | 2003 | 4465 | 0.110 |
Why?
|
DNA Primers | 2 | 2015 | 2819 | 0.110 |
Why?
|
History, 21st Century | 1 | 2019 | 1567 | 0.110 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2017 | 857 | 0.110 |
Why?
|
RNA Interference | 1 | 2021 | 2832 | 0.100 |
Why?
|
Transition Temperature | 1 | 2012 | 33 | 0.100 |
Why?
|
Protein Transport | 2 | 2012 | 1967 | 0.100 |
Why?
|
Guanosine | 1 | 2012 | 48 | 0.100 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 802 | 0.100 |
Why?
|
Cytidine | 1 | 2012 | 64 | 0.100 |
Why?
|
Australia | 1 | 2016 | 1250 | 0.100 |
Why?
|
Waist Circumference | 1 | 2016 | 935 | 0.100 |
Why?
|
Gene Knockdown Techniques | 2 | 2017 | 1612 | 0.100 |
Why?
|
Running | 1 | 2016 | 488 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2017 | 809 | 0.100 |
Why?
|
Dehydroepiandrosterone | 3 | 2002 | 258 | 0.090 |
Why?
|
History, 20th Century | 1 | 2019 | 2767 | 0.090 |
Why?
|
Community Mental Health Services | 1 | 2014 | 392 | 0.090 |
Why?
|
Receptors, Glucocorticoid | 1 | 2012 | 305 | 0.090 |
Why?
|
Rats, Inbred Strains | 5 | 1991 | 2088 | 0.090 |
Why?
|
Neoplasms | 1 | 2019 | 22173 | 0.090 |
Why?
|
Oxazines | 1 | 2012 | 350 | 0.090 |
Why?
|
Reproducibility of Results | 3 | 2017 | 20099 | 0.090 |
Why?
|
Genetic Engineering | 1 | 2015 | 933 | 0.080 |
Why?
|
Kidney Medulla | 1 | 1990 | 169 | 0.080 |
Why?
|
Exons | 1 | 2015 | 2391 | 0.080 |
Why?
|
HeLa Cells | 1 | 2015 | 3094 | 0.080 |
Why?
|
Glutathione | 2 | 2009 | 583 | 0.080 |
Why?
|
Walking | 1 | 2016 | 1198 | 0.080 |
Why?
|
I-kappa B Proteins | 1 | 2009 | 211 | 0.080 |
Why?
|
Adenosine Triphosphate | 2 | 2018 | 1989 | 0.080 |
Why?
|
Female | 21 | 2024 | 392686 | 0.080 |
Why?
|
bcl-2-Associated X Protein | 1 | 2009 | 282 | 0.080 |
Why?
|
MicroRNAs | 1 | 2024 | 3816 | 0.080 |
Why?
|
Cells, Cultured | 9 | 2007 | 18965 | 0.070 |
Why?
|
Body Weight | 1 | 2018 | 4618 | 0.070 |
Why?
|
Adenosine | 1 | 2012 | 808 | 0.070 |
Why?
|
Sodium | 2 | 1990 | 1588 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 3 | 2019 | 8181 | 0.070 |
Why?
|
3T3 Cells | 2 | 1999 | 1085 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3733 | 0.070 |
Why?
|
COS Cells | 2 | 1999 | 1130 | 0.070 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1749 | 0.070 |
Why?
|
Enzyme Inhibitors | 4 | 2002 | 3713 | 0.070 |
Why?
|
Conflict of Interest | 1 | 2011 | 554 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3877 | 0.070 |
Why?
|
Phosphorylation | 3 | 2005 | 8321 | 0.060 |
Why?
|
Mice, Knockout | 2 | 2018 | 14416 | 0.060 |
Why?
|
Group Processes | 1 | 2007 | 228 | 0.060 |
Why?
|
Renal Circulation | 1 | 1986 | 291 | 0.060 |
Why?
|
Streptozocin | 1 | 2005 | 194 | 0.060 |
Why?
|
Disease Progression | 6 | 2017 | 13510 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4244 | 0.060 |
Why?
|
Protein Kinase C | 1 | 2009 | 1202 | 0.060 |
Why?
|
Hexosamines | 1 | 2004 | 40 | 0.060 |
Why?
|
Environmental Pollutants | 1 | 2014 | 1277 | 0.060 |
Why?
|
Homozygote | 1 | 2009 | 1776 | 0.060 |
Why?
|
Rats, Zucker | 1 | 2024 | 131 | 0.060 |
Why?
|
Adult | 11 | 2024 | 221203 | 0.060 |
Why?
|
Apoptosis | 4 | 2019 | 9489 | 0.060 |
Why?
|
Uric Acid | 1 | 2010 | 807 | 0.060 |
Why?
|
Amyloid beta-Peptides | 1 | 1997 | 3839 | 0.060 |
Why?
|
Cyclic AMP-Dependent Protein Kinase Type II | 1 | 2002 | 10 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6312 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2012 | 12794 | 0.050 |
Why?
|
omega-N-Methylarginine | 1 | 2002 | 108 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15501 | 0.050 |
Why?
|
Malate Dehydrogenase | 1 | 2002 | 40 | 0.050 |
Why?
|
Angiotensin II | 1 | 1986 | 849 | 0.050 |
Why?
|
Nitric Oxide Synthase | 2 | 2002 | 908 | 0.050 |
Why?
|
Heterozygote | 1 | 2009 | 2787 | 0.050 |
Why?
|
Middle Aged | 11 | 2024 | 220920 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2007 | 1171 | 0.050 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 22172 | 0.050 |
Why?
|
Aldosterone | 1 | 2007 | 870 | 0.050 |
Why?
|
Young Adult | 4 | 2016 | 59255 | 0.050 |
Why?
|
Pterins | 1 | 2001 | 11 | 0.050 |
Why?
|
Kidney Function Tests | 2 | 2016 | 679 | 0.050 |
Why?
|
Risk Factors | 7 | 2017 | 74213 | 0.050 |
Why?
|
Base Sequence | 1 | 2012 | 12441 | 0.050 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2002 | 517 | 0.050 |
Why?
|
Inflammation | 2 | 2018 | 10773 | 0.050 |
Why?
|
Comorbidity | 3 | 2023 | 10508 | 0.050 |
Why?
|
NF-kappa B | 1 | 2009 | 2490 | 0.050 |
Why?
|
Program Development | 1 | 2007 | 1297 | 0.050 |
Why?
|
Time Factors | 6 | 2017 | 39970 | 0.050 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2000 | 201 | 0.050 |
Why?
|
Endothelial Growth Factors | 1 | 2003 | 673 | 0.050 |
Why?
|
Health Care Costs | 1 | 2014 | 3242 | 0.040 |
Why?
|
Public Health | 1 | 2014 | 2669 | 0.040 |
Why?
|
Up-Regulation | 1 | 2009 | 4124 | 0.040 |
Why?
|
Lymphokines | 1 | 2003 | 927 | 0.040 |
Why?
|
Risk Assessment | 3 | 2017 | 23996 | 0.040 |
Why?
|
Interpersonal Relations | 1 | 2007 | 1436 | 0.040 |
Why?
|
Congenital Abnormalities | 1 | 2004 | 709 | 0.040 |
Why?
|
Carrier Proteins | 2 | 1990 | 4937 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2014 | 16986 | 0.040 |
Why?
|
Hydrogen Peroxide | 2 | 2001 | 730 | 0.040 |
Why?
|
Placebos | 1 | 2003 | 1667 | 0.040 |
Why?
|
PC12 Cells | 1 | 1999 | 317 | 0.040 |
Why?
|
Ribosemonophosphates | 1 | 1998 | 7 | 0.040 |
Why?
|
Boston | 2 | 2012 | 9326 | 0.040 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1984 | 1492 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 12954 | 0.040 |
Why?
|
Models, Biological | 2 | 2012 | 9469 | 0.040 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2017 | 705 | 0.040 |
Why?
|
Blotting, Western | 2 | 2017 | 5035 | 0.040 |
Why?
|
Receptor, Bradykinin B1 | 1 | 2017 | 11 | 0.040 |
Why?
|
Parathyroid Hormone | 1 | 1984 | 1803 | 0.040 |
Why?
|
Receptor, Bradykinin B2 | 1 | 2017 | 24 | 0.040 |
Why?
|
Mice, Inbred DBA | 1 | 2019 | 621 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 489 | 0.040 |
Why?
|
Neurons | 1 | 1997 | 9463 | 0.040 |
Why?
|
Learning | 1 | 2007 | 1740 | 0.040 |
Why?
|
Diabetes Complications | 1 | 2004 | 1315 | 0.040 |
Why?
|
Health Behavior | 2 | 2023 | 2644 | 0.040 |
Why?
|
Primary Health Care | 1 | 2014 | 4686 | 0.040 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2019 | 305 | 0.040 |
Why?
|
Aged | 6 | 2024 | 169310 | 0.040 |
Why?
|
Basal Metabolism | 1 | 2018 | 161 | 0.030 |
Why?
|
Kininogens | 1 | 2016 | 15 | 0.030 |
Why?
|
Receptors, Bradykinin | 1 | 2016 | 19 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2012 | 10448 | 0.030 |
Why?
|
Prevalence | 1 | 2014 | 15732 | 0.030 |
Why?
|
Liver | 1 | 2012 | 7529 | 0.030 |
Why?
|
Blood | 1 | 1999 | 596 | 0.030 |
Why?
|
Signal Transduction | 2 | 2002 | 23447 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2014 | 5440 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2017 | 256 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2003 | 1349 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1651 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26127 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 1999 | 6214 | 0.030 |
Why?
|
Insulin | 1 | 2009 | 6597 | 0.030 |
Why?
|
1-Methyl-4-phenylpyridinium | 1 | 2014 | 34 | 0.030 |
Why?
|
Rotenone | 1 | 2014 | 45 | 0.030 |
Why?
|
Kidney Glomerulus | 1 | 2017 | 568 | 0.030 |
Why?
|
Saponins | 1 | 1994 | 46 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 10212 | 0.030 |
Why?
|
Oxidopamine | 1 | 2014 | 172 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1990 | 2496 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2007 | 6228 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2002 | 10766 | 0.030 |
Why?
|
Sleep Deprivation | 1 | 2020 | 846 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 2007 | 3249 | 0.030 |
Why?
|
Herbicides | 1 | 2014 | 105 | 0.030 |
Why?
|
Tyrosine | 1 | 1998 | 1440 | 0.030 |
Why?
|
Type C Phospholipases | 1 | 1994 | 287 | 0.030 |
Why?
|
Organ Specificity | 1 | 2018 | 1968 | 0.030 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 266 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2468 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 1994 | 575 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2024 | 3677 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2014 | 39107 | 0.020 |
Why?
|
Peptide Fragments | 1 | 1984 | 5112 | 0.020 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 1994 | 435 | 0.020 |
Why?
|
Phosphogluconate Dehydrogenase | 1 | 1991 | 22 | 0.020 |
Why?
|
Fasting | 1 | 2018 | 1603 | 0.020 |
Why?
|
Ionomycin | 1 | 1991 | 110 | 0.020 |
Why?
|
Guanine Nucleotides | 1 | 1991 | 55 | 0.020 |
Why?
|
Virulence Factors, Bordetella | 1 | 1991 | 154 | 0.020 |
Why?
|
Pertussis Toxin | 1 | 1991 | 176 | 0.020 |
Why?
|
Streptolysins | 1 | 1991 | 57 | 0.020 |
Why?
|
Inositol Phosphates | 1 | 1991 | 176 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1334 | 0.020 |
Why?
|
Cycloheximide | 1 | 1991 | 343 | 0.020 |
Why?
|
Docosahexaenoic Acids | 1 | 2018 | 908 | 0.020 |
Why?
|
Brain | 1 | 2018 | 27120 | 0.020 |
Why?
|
Cyclic GMP | 2 | 2003 | 395 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2192 | 0.020 |
Why?
|
Urinary Tract Infections | 1 | 2017 | 802 | 0.020 |
Why?
|
Aging | 1 | 2009 | 8711 | 0.020 |
Why?
|
Ethylmaleimide | 1 | 1990 | 70 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2004 | 2947 | 0.020 |
Why?
|
Ammonium Chloride | 1 | 1990 | 72 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1991 | 817 | 0.020 |
Why?
|
Amiloride | 1 | 1990 | 116 | 0.020 |
Why?
|
Proton-Translocating ATPases | 1 | 1990 | 112 | 0.020 |
Why?
|
Sequence Deletion | 1 | 1994 | 1494 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2012 | 492 | 0.020 |
Why?
|
Hypoglycemia | 1 | 2017 | 883 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 1986 | 9177 | 0.020 |
Why?
|
Isoenzymes | 1 | 1994 | 1687 | 0.020 |
Why?
|
Epithelium | 1 | 1994 | 1603 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2016 | 80646 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3882 | 0.020 |
Why?
|
Dogs | 1 | 1994 | 3839 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 2049 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3725 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1886 | 0.020 |
Why?
|
Serum Albumin | 1 | 2012 | 672 | 0.020 |
Why?
|
Quality of Life | 1 | 2010 | 13367 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2014 | 12463 | 0.020 |
Why?
|
Metabolomics | 1 | 2017 | 1659 | 0.020 |
Why?
|
Quality Improvement | 1 | 2023 | 3801 | 0.020 |
Why?
|
Metabolome | 1 | 2014 | 989 | 0.020 |
Why?
|
Dopamine | 1 | 2014 | 1607 | 0.020 |
Why?
|
Cyclic AMP Response Element Modulator | 1 | 2007 | 88 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1994 | 1626 | 0.020 |
Why?
|
Protein Binding | 1 | 2019 | 9353 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2007 | 293 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22176 | 0.020 |
Why?
|
Microvilli | 1 | 1986 | 234 | 0.020 |
Why?
|
Gene Expression | 1 | 1999 | 7581 | 0.020 |
Why?
|
Natriuresis | 1 | 1986 | 105 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3416 | 0.020 |
Why?
|
Histocytochemistry | 1 | 1986 | 698 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2007 | 1545 | 0.020 |
Why?
|
Sleep | 1 | 2020 | 4768 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 1994 | 2865 | 0.010 |
Why?
|
Protons | 1 | 1990 | 1116 | 0.010 |
Why?
|
Pregnancy | 2 | 2023 | 29876 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1994 | 6534 | 0.010 |
Why?
|
Glucosamine | 1 | 2004 | 128 | 0.010 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2007 | 855 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2014 | 3769 | 0.010 |
Why?
|
Mice, Inbred ICR | 1 | 2004 | 364 | 0.010 |
Why?
|
Adolescent | 3 | 2023 | 88324 | 0.010 |
Why?
|
Immunoblotting | 1 | 2007 | 1646 | 0.010 |
Why?
|
Xanthine | 1 | 2003 | 11 | 0.010 |
Why?
|
Proteomics | 1 | 2017 | 3848 | 0.010 |
Why?
|
Phosphates | 1 | 1987 | 770 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1986 | 2561 | 0.010 |
Why?
|
Spironolactone | 1 | 2007 | 412 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12341 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5769 | 0.010 |
Why?
|
Xanthine Oxidase | 1 | 2003 | 69 | 0.010 |
Why?
|
DNA Replication | 1 | 1990 | 1418 | 0.010 |
Why?
|
Biological Transport | 1 | 1987 | 2091 | 0.010 |
Why?
|
Kinetics | 1 | 1990 | 6374 | 0.010 |
Why?
|
Biological Availability | 1 | 2003 | 390 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5872 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2007 | 1206 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2003 | 748 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1994 | 2297 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6484 | 0.010 |
Why?
|
Pteridines | 1 | 2001 | 47 | 0.010 |
Why?
|
Heart Failure | 1 | 1986 | 11670 | 0.010 |
Why?
|
Antigens | 1 | 1986 | 1443 | 0.010 |
Why?
|
Cell Separation | 1 | 1986 | 1720 | 0.010 |
Why?
|
Amino Acids | 1 | 1987 | 1718 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12059 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15266 | 0.010 |
Why?
|
Vasodilation | 1 | 1984 | 962 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2017 | 58986 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12947 | 0.010 |
Why?
|
Child | 2 | 2023 | 80156 | 0.010 |
Why?
|
Embryonic Development | 1 | 2004 | 721 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2017 | 64684 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1994 | 4319 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12725 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14607 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1986 | 3807 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2003 | 3492 | 0.010 |
Why?
|
Prognosis | 1 | 2012 | 29629 | 0.010 |
Why?
|
Cell Movement | 1 | 2003 | 5205 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 54426 | 0.010 |
Why?
|
Child, Preschool | 1 | 2012 | 42230 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1986 | 11461 | 0.000 |
Why?
|